Zhang Wei, Matsumoto-Takasaki Ayano, Kusada Yu, Sakaue Hiroyuki, Sakai Keiko, Nakata Munehiro, Fujita-Yamaguchi Yoko
Institute of Glycotechnology, Tokai University, Kanagawa 259-1292, Japan.
Biochemistry. 2007 Jan 9;46(1):263-70. doi: 10.1021/bi0618767.
Since phage-display technology is probably the best available strategy to produce antibodies directed against various carbohydrate moieties, we employed phage-display technology to generate human single chain antibodies (scFvs) using neoglycolipids as carbohydrate antigens. An accompanying paper in this issue describes how phage-displayed antibodies (phage Abs) that recognized nonreducing terminal mannose residues were isolated and characterized. In this study, four independent scFv genes, isolated by a mannotriose (Man3)-bearing lipid as an antigen as previously described, were used to construct expression vectors to produce soluble scFv proteins in quantity. Both bacterial and mammalian expression systems were used to produce glutathione S-transferase-scFv fusion proteins and scFv-human IgG1 Fc conjugates, respectively. The expressed scFv fusion proteins were purified to apparent homogeneity with yields of approximately 1 and 48 mg, from 1 L of bacterial culture and myeloma cell media, respectively. Surface plasmon resonance and ELISA analyses confirmed that purified scFv proteins showed Man3 specificity. The humanized antibody in scFv-Fc form, derived from clone 5A3, was a disulfide-liked dimer with a molecular mass of 108 kDa. According to a bivalent model, the kinetics parameters of its binding to Man3 were determined to be ka = 4.03 x 104 M-1 s-1, kd = 5.77 x 10-4 s-1, KA = 6.98 x 107 M-1, and KD = 1.43 x 10-8 M. This study thus established the foundation for isolation of carbohydrate-specific scFv genes and eventual production of humanized scFv-Fc type antibodies.
由于噬菌体展示技术可能是生产针对各种碳水化合物部分的抗体的最佳可用策略,我们采用噬菌体展示技术,以新糖脂作为碳水化合物抗原生成人单链抗体(scFv)。本期的一篇配套论文描述了如何分离和表征识别非还原末端甘露糖残基的噬菌体展示抗体(噬菌体抗体)。在本研究中,如前所述,使用含甘露三糖(Man3)的脂质作为抗原分离出的四个独立scFv基因,用于构建表达载体,以大量生产可溶性scFv蛋白。细菌和哺乳动物表达系统分别用于生产谷胱甘肽S-转移酶-scFv融合蛋白和scFv-人IgG1 Fc缀合物。从1 L细菌培养物和骨髓瘤细胞培养基中分别纯化得到的scFv融合蛋白,产率约为1 mg和48 mg,达到明显的均一性。表面等离子体共振和ELISA分析证实,纯化的scFv蛋白具有Man3特异性。源自克隆5A3的scFv-Fc形式的人源化抗体是一种分子量为108 kDa的二硫键连接的二聚体。根据二价模型,其与Man3结合的动力学参数确定为ka = 4.03 x 104 M-1 s-1,kd = 5.77 x 10-4 s-1,KA = 6.98 x 107 M-1,KD = 1.43 x 10-8 M。因此,本研究为分离碳水化合物特异性scFv基因以及最终生产人源化scFv-Fc型抗体奠定了基础。